Top Page
Charlotte's Web Holdings
(TSX:CWEB)
Charlotte's Web Holdings (CWEB) vs. iShares MSCI Canada ETF (EWC)
Charlotte's Web Holdings Business Overview & Revenue Model
Charlotte's Web Holdings Earnings Call Summary
Charlotte's Web Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.32M | 49.67M | 63.16M | 74.14M | 96.09M | 95.23M |
| Gross Profit | 23.99M | 21.26M | 35.57M | 19.41M | 48.59M | 52.26M |
| EBITDA | -12.94M | -22.01M | -24.90M | -41.68M | -38.03M | -44.49M |
| Net Income | -21.66M | -29.85M | -23.80M | -59.31M | -137.72M | -30.68M |
Balance Sheet | ||||||
| Total Assets | 87.98M | 113.44M | 152.55M | 187.64M | 171.51M | 310.88M |
| Cash, Cash Equivalents and Short-Term Investments | 15.27M | 22.62M | 48.99M | 69.28M | 20.42M | 55.55M |
| Total Debt | 63.10M | 59.34M | 60.44M | 57.63M | 22.60M | 23.36M |
| Total Liabilities | 73.05M | 86.36M | 96.99M | 110.14M | 41.07M | 56.65M |
| Stockholders Equity | 14.93M | 27.09M | 55.56M | 77.50M | 130.45M | 254.23M |
Cash Flow | ||||||
| Free Cash Flow | -17.35M | -25.11M | -19.08M | -5.58M | -34.48M | -76.85M |
| Operating Cash Flow | -16.16M | -21.26M | -15.39M | -5.32M | -29.56M | -48.59M |
| Investing Cash Flow | -1.05M | -3.80M | -3.51M | 395.00K | -11.79M | -19.44M |
| Financing Cash Flow | -52.00K | -145.00K | -251.00K | 52.39M | 8.04M | 55.44M |
Charlotte's Web Holdings Technical Analysis
Charlotte's Web Holdings Risk Analysis
Charlotte's Web Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | C$65.61M | ― | -20.91% | ― | 36.50% | -306.47% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | $33.25M | 183.33 | 0.61% | ― | 34.19% | ― | |
49 Neutral | $29.44M | -0.97 | -85.33% | ― | -5.03% | 50.71% | |
49 Neutral | C$58.89M | ― | -10.63% | ― | 21.71% | 18.75% | |
45 Neutral | $28.86M | -18.28 | -109.32% | ― | 2.00% | 80.83% | |
44 Neutral | C$20.50M | ― | -15.75% | ― | 26.75% | 61.79% |
Charlotte's Web Holdings Corporate Events
Charlotte’s Web Holdings has appointed M. Borgia Walker to its Board of Directors, effective November 1, 2025. Walker brings three decades of experience in transformation and financial leadership from the global consumer goods and financial services industries. Her expertise in organizational transformation, finance, and regulatory compliance is expected to support Charlotte’s Web’s strategic objectives and enhance its market leadership. This appointment aligns with the company’s values of sustainability and social responsibility, and is seen as a strategic move to strengthen its board and continue its growth trajectory.
The most recent analyst rating on (TSE:CWEB) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Charlotte’s Web Holdings stock, see the TSE:CWEB Stock Forecast page.
Charlotte’s Web Holdings has expanded its Brightside line with the launch of Knockout Hemp THC Sleep Gummies, designed to enhance sleep quality by combining hemp-derived THC and CBN with a rapid-onset delivery system. This new product aims to capture the growing demand for natural sleep solutions, reinforcing the company’s position as a leader in the hemp wellness category and broadening its portfolio of science-backed formulations.
The most recent analyst rating on (TSE:CWEB) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Charlotte’s Web Holdings stock, see the TSE:CWEB Stock Forecast page.
Charlotte’s Web Holdings has launched Quiet Sleep Mushroom Gummies, expanding its product line in the sleep and relaxation category. This new melatonin-free and CBD-free product, which combines reishi mushroom, chamomile, and magnesium, addresses consumer demand for natural sleep aids and positions the company to capitalize on the growing functional mushroom and sleep-support markets.
On September 16, 2025, Jonathan Atwood announced his resignation from the Board of Directors at Charlotte’s Web Holdings, effective October 1, 2025. His departure is not due to any disagreements with the company’s operations, policies, or financial practices, indicating a smooth transition without internal conflict.
Charlotte’s Web Holdings, a leader in hemp-derived CBD wellness, has announced the formation of a Scientific Advisory Board to enhance its medical strategy and accelerate research and development efforts. This initiative aims to strengthen the company’s focus on science-backed innovation and expand patient access to plant-based therapeutics. The board will guide clinical initiatives and product formulations, addressing gaps in patient care for conditions like pain and anxiety. Additionally, the company is collaborating with DeFloria, Inc. and Ajna BioSciences PBC on a botanical drug candidate for autism spectrum disorder, which has received FDA approval for Phase 2 clinical trials.
Charlotte’s Web Holdings’ latest earnings call revealed a cautiously optimistic outlook amidst ongoing challenges. The company demonstrated positive revenue growth and strategic expansion, despite facing industry headwinds and regulatory uncertainty. Cost-saving measures and innovative product launches are positioning the company for future profitability, although current financials still reflect challenges with negative EBITDA and net loss.
Charlotte’s Web Holdings, Inc., a Certified B Corp based in Louisville, Colorado, specializes in producing high-quality hemp-derived wellness products, including CBD oils, gummies, and pet products, primarily for the U.S. market. In its latest earnings report for the quarter ending June 30, 2025, Charlotte’s Web Holdings reported a slight increase in revenue to $12.8 million compared to $12.3 million in the same period last year, alongside a significant reduction in net loss from $11.1 million to $6.3 million. The company achieved a gross profit of $6 million, up from $2.6 million, due to improved cost management, although it continues to face challenges with operating losses and an accumulated deficit. Strategic highlights include the termination of a costly promotional agreement with Major League Baseball, which resulted in a gain of $2.3 million, and ongoing investments in research and development through its CW Labs division. Looking ahead, Charlotte’s Web Holdings remains focused on enhancing operational efficiencies and expanding its product offerings, while navigating the regulatory landscape for hemp-derived products in the U.S.
Charlotte’s Web Holdings reported its second consecutive quarter of year-over-year revenue growth, driven by new product innovations and omnichannel expansion. The company has successfully internalized the production of its Brightside™ gummies, leading to cost savings and improved margins. The launch of new product categories, including CBG Focus & Attention Gummies and functional mushroom gummies, has diversified its portfolio and strengthened its position in high-growth wellness markets. The company continues to focus on cost management and operational improvements to approach positive cash flow, while also engaging in regulatory efforts to advance federal regulation of hemp-derived products.
Charlotte’s Web Holdings announced it will release its 2025 second quarter earnings on August 13, 2025, followed by a conference call to discuss the results. This announcement is significant for stakeholders as it provides insights into the company’s financial health and market performance, reinforcing its position as a leader in the CBD industry.
The most recent analyst rating on (TSE:CWEB) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Charlotte’s Web Holdings stock, see the TSE:CWEB Stock Forecast page.